A 52-year-old male patient with a history of chronic alcoholism presents for elective laparoscopic cholecystectomy. During induction, the anesthesiologist plans to use sevoflurane for maintenance. Intraoperatively, the patient develops unexpected tachycardia (HR 120/min), hypertension (BP 160/95 mmHg), and muscle rigidity. The anesthesiologist suspects malignant hyperthermia and immediately discontinues sevoflurane. Core temperature at this point is 37.8°C. Which property of sevoflurane most likely contributed to the rapid onset of this clinical picture and why is its discontinuation immediately effective?

Explanation

## Sevoflurane Pharmacokinetics and Malignant Hyperthermia Trigger ### Why Sevoflurane's Low Blood-Gas Solubility is Critical Here **Key Point:** Sevoflurane has a blood-gas solubility coefficient of 0.65, making it one of the least soluble volatile anesthetics. This low solubility means: 1. Rapid rise in alveolar partial pressure → rapid increase in brain concentration → fast onset of anesthesia and rapid development of depth changes 2. Rapid elimination from the body when the vaporizer is turned off → immediate cessation of the triggering agent ### Malignant Hyperthermia Context **Clinical Pearl:** In a patient with malignant hyperthermia susceptibility (MHS), volatile anesthetics are known triggers. The combination of: - Sevoflurane's rapid onset (due to low solubility) → deep anesthesia achieved quickly - Possible underlying MHS (suggested by the acute hypermetabolic response: tachycardia, hypertension, muscle rigidity) - Early core temperature elevation (37.8°C is already borderline) The rapid discontinuation of sevoflurane is immediately effective because its low blood-gas solubility ensures rapid washout from the central nervous system and body, stopping the triggering stimulus within minutes. ### Comparison of Volatile Agent Solubilities | Agent | Blood-Gas Solubility | Clinical Implication | |-------|----------------------|----------------------| | Sevoflurane | 0.65 | Rapid onset/offset; fastest emergence | | Isoflurane | 1.15 | Intermediate onset/offset | | Halothane | 2.54 | Slow onset/offset; prolonged recovery | | Desflurane | 0.42 | Fastest onset/offset; airway irritant | **High-Yield:** Lower blood-gas solubility = faster alveolar rise = faster CNS effect = faster elimination. This is why sevoflurane is preferred in pediatric anesthesia and rapid-sequence scenarios. ### Why Immediate Discontinuation Works When sevoflurane is turned off: 1. Alveolar concentration drops instantly 2. Concentration gradient reverses (blood to alveoli) 3. Rapid elimination via lungs (not dependent on hepatic metabolism) 4. Triggering stimulus removed within 5–10 minutes 5. MH cascade can be halted before fulminant rhabdomyolysis and hyperkalemia **Warning:** Do NOT confuse sevoflurane's low solubility with potency (MAC). Low solubility ≠ high potency. Sevoflurane's MAC is 2%, which is moderate. [cite:Miller's Anesthesia 8e Ch 3]